Compare Cigna Corp (CI) vs VanEck Junior Gold Miners (GDXJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cigna Corp vs VanEck Junior Gold Miners — how do they compare? Cigna Corp trades at $272.72 (market cap $73.56B), while VanEck Junior Gold Miners trades at $119.59. The key difference: Cigna Corp pays a 2.24% dividend while VanEck Junior Gold Miners pays none, and VanEck Junior Gold Miners is trading nearer its 52-week high, Cigna Corp nearer its low. Which is the better fit depends on your goals.
| CI | GDXJ | |
|---|---|---|
Market Cap | $73.56B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $311.00 | $156.19 |
52-Week Low | $244.41 | $71.22 |
Enterprise Value | $98.27B | — |
Dividend Yield | 2.24% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cigna (CI) trades at $282.49, up 2.63% with strong earnings beats in recent quarters. The stock shows bearish technical signals but benefits from low valuation ratios like a P/E of 11.68 and P/S of 0.27. Recent Q2 2026 results exceeded expectations, with EPS of $7.78 beating estimates, and the company raised its full-year guidance to at least $30.45 adjusted EPS, reflecting robust growth in health services and insurance segments.
The outlook is positive due to consistent earnings outperformance and raised guidance, though technical weakness and competitive pressures pose risks. Analyst consensus is strongly bullish with a $338.90 price target, indicating ~20% upside potential from current levels, supported by dividend payments and institutional accumulation.
GDXJ (VanEck Junior Gold Miners ETF) trades at $117.57, up 7.47% in the last 24 hours, with a bullish technical signal from moving averages but bearish oscillators. The ETF shows strong momentum with ADX indicating a trending market, though RSI levels suggest potential overbought conditions. Recent institutional activity includes Amundi reducing its stake by 50.5% in the latest quarter (SEC Form 13F filing, August 2026).
The outlook for GDXJ is mixed—bullish technical trends conflict with bearish sentiment from oscillators and institutional selling. Key risks include gold price volatility and Federal Reserve policy impacts. Investment opportunity hinges on gold market strength, but caution is warranted given overbought signals and recent underperformance versus peers.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cigna Corp
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →About VanEck Junior Gold Miners
GDXJ provides exposure to small and mid-cap companies in the global gold and silver mining industry. It focuses on 'junior' miners involved in exploration and early production, featuring 2026 leaders like Pan American Silver and Coeur Mining.
Read more on GDXJ →
